Affiliation: Montana State University
Khlebnikov A, Schepetkin I, Kishkentaeva A, Shaimerdenova Z, Atazhanova G, Adekenov S, et al
. Inhibition of T Cell Receptor Activation by Semi-Synthetic Sesquiterpene Lactone Derivatives and Molecular Modeling of Their Interaction with Glutathione and Tyrosine Kinase ZAP-70. Molecules. 2019;24: pubmed publisher
..We suggest that natural and/or semi-synthetic SLs with an α -methylene- γ -lactone moiety can specifically target GSH and the kinase site of ZAP-70 and inhibit the initial phases of TCR activation. ..
Schepetkin I, Khlebnikov A, Potapov A, Kovrizhina A, Matveevskaya V, Belyanin M, et al
. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors. Eur J Med Chem. 2019;161:179-191 pubmed publisher
..Thus, oximes with indenoquinoxaline and tryptanthrin nuclei can serve as specific small-molecule modulators for mechanistic studies of JNK, as well as potential leads for the development of anti-inflammatory drugs. ..
Utegenova G, Pallister K, Kushnarenko S, Ozek G, Ozek T, Abidkulova K, et al
. Chemical Composition and Antibacterial Activity of Essential Oils from Ferula L. Species against Methicillin-Resistant Staphylococcus aureus. Molecules. 2018;23: pubmed publisher
..Overall, these results suggest that the EOs from F. ovina could have potential for use as alternative remedies for the treatment of infectious diseases caused by MRSA. ..
Schepetkin I, Kirpotina L, Hammaker D, Kochetkova I, Khlebnikov A, Lyakhov S, et al
. Anti-Inflammatory Effects and Joint Protection in Collagen-Induced Arthritis after Treatment with IQ-1S, a Selective c-Jun N-Terminal Kinase Inhibitor. J Pharmacol Exp Ther. 2015;353:505-16 pubmed publisher
..Thus, IQ-1S can reduce inflammation and cartilage loss associated with CIA and can serve as a small-molecule modulator for mechanistic studies of JNK function in rheumatoid arthritis. ..
Schepetkin I, Khlebnikov A, Kirpotina L, Quinn M. Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives. Int Immunopharmacol. 2016;37:43-58 pubmed publisher
..The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes. ..
Schepetkin I, Khlebnikov A, Giovannoni M, Kirpotina L, Cilibrizzi A, Quinn M. Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition. Curr Med Chem. 2014;21:1478-504 pubmed
..Application of computational models for virtual screening and design of FPR ligands is also considered. ..
Schepetkin I, Kirpotina L, Khlebnikov A, Cheng N, Ye R, Quinn M. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones. Biochem Pharmacol. 2014;92:627-41 pubmed publisher
..Thus, the chromone/isoflavone scaffold represents a relevant backbone for development of novel FPR1 antagonists. ..
Zykova M, Schepetkin I, Belousov M, Krivoshchekov S, Logvinova L, Bratishko K, et al
. Physicochemical Characterization and Antioxidant Activity of Humic Acids Isolated from Peat of Various Origins. Molecules. 2018;23: pubmed publisher
..Overall, these data provide a molecular basis to explain at least part of the beneficial therapeutic properties of peat-derived HAs. ..
Kouakou K, Schepetkin I, Jun S, Kirpotina L, Yapi A, Khramova D, et al
. Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: beneficial effects in experimental autoimmune encephalomyelitis. BMC Complement Altern Med. 2013;13:149 pubmed publisher
..However, little is known about the high-molecular weight active components conferring therapeutic properties to these extracts...